About ES-Barcelona-ICODURANREYNALS
Clinical Trials at ES-Barcelona-ICODURANREYNALS
During the past decade, ES-Barcelona-ICODURANREYNALS conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "ES-Barcelona-ICODURANREYNALS"
#1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator and "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at ES-Barcelona-ICODURANREYNALS
According to Clinical.Site data, the most researched conditions in "ES-Barcelona-ICODURANREYNALS" are
"Acute Myeloid Leukemia" (2 trials) and "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials). Many other conditions were trialed in "ES-Barcelona-ICODURANREYNALS" in a lesser frequency.
Clinical Trials Intervention Types at ES-Barcelona-ICODURANREYNALS
Most popular intervention types in "ES-Barcelona-ICODURANREYNALS" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "AG-120" (1 trials), "AG-221" (1 trials), "Gilteritinib" (1 trials), "Midostaurin" (1 trials) and "Placebo for AG-120" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ES-Barcelona-ICODURANREYNALS
The vast majority of trials in "ES-Barcelona-ICODURANREYNALS" are
2 trials for "All" genders.
Clinical Trials Status at ES-Barcelona-ICODURANREYNALS
Currently, there are NaN active trials in "ES-Barcelona-ICODURANREYNALS".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in ES-Barcelona-ICODURANREYNALS,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in ES-Barcelona-ICODURANREYNALS, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".